The Toxicology of Mycotoxins

References

• Hirata Y. On the products of mould. I. Poisonous substance from mouldy rice (Part 1), extraction (in Japanese). J. Jpn. Chem. Soc. 1947; 68: 63
   Google Scholar
• Hirata Y. On the products of mould. II. Poisonous substances from mouldy rice (Part 2), molecular weight (in Japanese). J. Jpn. Chem. Soc. 1947; 68: 74
   Google Scholar
• Hirata Y. On the products of mould. III, IV (in Japanese). J. Jpn. Chem. Soc. 1947; 68: 104
   Google Scholar
• Udagawa S. Taxonomic studies of fungi on stored rice grains. III.Penicillium group (Penicillia and related genera). II. J. Agric. Sci. Tokyo Nogya Daigaku 1959; 5: 10
   Google Scholar
• Nagel D. W., Steyn P. Production of citrcoviridin by. Penicillium pulvullorum, Phytochemistry 1972; 11: 627
   Web of Science ®Google Scholar
• Tsunoda H., Tsuruta O., Takahashi M. Researches for the microorganisms which deteriorate the stored cereals. XVII. Parasites of imported rice. I (in Japanese). Bull. Food Res. Inst. 1958; 13: 29
   Google Scholar
• Ueno Y. Citreoviridin fromPenicillium citreo-viride Biourge. Mycotoxins, I. F. H. Purchase. Elsevier/North Holland, New York 1974; 283.
   Google Scholar
• Uraguchi K. Pharmacology of mycotoxins. International Encylcopedia of Pharmacology and Toxicology, Section 71, H. Raskova. Pergamon Press, New York 1971; chap. 17.
   Google Scholar
• Ueno Y. Production of citreoviridin, a neurotoxic mycotoxin ofPenicillium citreo-viride Biourge. Mycotoxins in Human Health, F. H. PurchaseI. MacMillan, London 1974; 115.
   Google Scholar
• Ueno Y, Ueno I. Isolation and acute toxicity of citreoviridin, a neurotoxic mycotoxin ofPenicillium citreo-viride Biourge. Jpn. J. Exp. Med. 1972; 42: 91
   PubMedGoogle Scholar
• Sakabe N., Goto T., Hirate Y. The structure of citreoviridin, a toxic compound produced byP. citreoviride molded on rice. Tetrahedron Lett. 1964; 27: 1825
   Google Scholar
• Linnett P. R., Mitchell A. D., Osselton M. D., Mulheirn L. J., Beechey R. B. Citreovidirin, a specific inhibitor of the mitochondrial adenosine triphosphatase. Biochem. J. 1981; 170: 503
   Google Scholar
• Uraguchi K. Pharmacological studies on the toxicity of the “O-hen-mai” (yellowed rice). I. Evidence of a toxin in the yellowed rice polluted byPenicillium sp. (in Japanese). Nisshin Igaku 1947; 34: 155
   Google Scholar
• Uraguchi K. Toxicological studies on the toxicity of the yellowed rice “O-hen-mai”. VIII. Site of action of the yellowed rice toxin and cause of death in the acute poisoning (in Japanese). Nisshin Igaku 1955; 42: 690
   Google Scholar
• Uraguchi K. Mycotoxic origin of cardiac beriberi. J. Stored Prod. Res. 1969; 5: 227
   Web of Science ®Google Scholar
• Mulheirn L. J., Beechery R. B., Leworthy D. P. Aurovertin B, a metabolite of Calcarisoporium arbuscula. J. C. S. Chem. Comm. 1974; 874
   Google Scholar
• Roberton A. M., Beechey R. B., Holloway C. T., Knight I. G. The effect of aurovertin on a soluble mitochondrial adenosine triphosphatase. Biochem. J. 1967; 104: 54c
   Google Scholar
• Beechey R. B., Osselton D. O., Baum H., Linnett P. E., Mitchell A. D. Citreoviridin diacetate. A new inhibitor of the mitochondrial ATP-synthetase. Membrane Proteins in Transport and Phosphorylation, E. Quagliariello, N. Siliprandi. Elsevier/North-Holland, Amsterdam 1974; 201.
   Google Scholar
• Kruger G. J., Steyn P. S., Vleggaar R. X-ray crystal structure of asteltoxin, a novel mycotoxin fromAspergillus stellatus Curzi. J. C. S. Chem. Comm. 1979; 441
   Google Scholar
• Maebayashi Y., Suzuki S., Murai T., Yamazaki M. Isolation and toxicity of asteltoxin produced by. Emecicella variecolor, Proc. Jpn. Assoc. Mycotoxicol. 1983; 17: 47
   Google Scholar
• Verschoor G. J., Sluis P. R., Van der Slater E. C. The binding of aurovertin to isolated subunit of F, (mitochondrial ATPase). Stoichiometry of β subunit in F1. Biochim. Biophys. Acta 1977; 462: 438
   Google Scholar
• Douglas M. G., Koh Y., Ebner E., Agsteribbe E., Schatz G. A nuclear mutation conferring aurovertin resistance to yeast mitochondrial adenosine triphosphatase. J. Biol. Chem. 1979; 254: 1335
   Google Scholar
• Gause E. M., Buck M. A., Douglas M. G. Binding of citreoviridin to the β subunit of the yeast F-ATPase. J. Biol. Chem. 1981; 256: 557
   PubMed Web of Science ®Google Scholar
• Datta S. C., Sengupta D., Ghosh J. J. Toxicity of citreoviridin, a neurotoxic mycotoxin ofPenicillium citreo-viride, on glycogen metabolism of rat heart. Ind. J. Pharmacol. 1979; 11: 84
   Google Scholar
• Datta S. C., Ghosh J. J. Effect of citreoviridin, a metabolite fromPenicillium citreoviride NRRL 2579, on glycogen metabolism of rat brain. Toxicon 1981; 19: 217
   Google Scholar
• Wicklow D. T., Cole R. J. Citreoviridin in standing corn infested byEupenicillium ochrosalmoneum Scott & Stolk. Can. J. Microbiol., in press
   Google Scholar
• Saito M., Enomoto M., Tatsuno T. Microbial Toxins, Vol. 6, A. Ciegler, S. Kadis, S. J. Ajl. Academic Press, New York 1971; 299.
   Google Scholar
• Ueno Y. Hydroxyanthraquinones (skyrines). Mycotoxins: Production, Isolation, Separation and Purification, V. Betina. Elsevier/North Holland, Amsterdam 1984; 329.
   Google Scholar
• Shibara S. Some recent studies on the metabolites of fungi and lichens. Pure Appl. Chem. 1973; 33: 109
   Google Scholar
• Ueno Y., Ueno I. Toxicology and biochemistry of mycotoxins. Toxicology: Biochemistry and Pathology of Mycotoxins, K. Uraguchi, M. Yamazaki. Kodansha, Tokyo 1978; 107.
   Google Scholar
• Uraguchi K., Ueno I., Ueno Y., Komai Y. Absorption, distribution and excretion of luteoskyrin with special reference to the selective action on the liver. Toxicol. Appl. Pharmacol. 1972; 21: 335
   Google Scholar
• Ueno Y., Ueno I., Sato N., Litoi Y., Saito M., Enomoto M., Tsunoda H. Toxicological approach to (+) rugulosin, an anthraquinoid mycotoxin of. Penicillium rugulosum Thom, Jpn. J. Exp. Med. 1971; 41: 177
   Google Scholar
• Sato N., Ueno Y., Ueno I. Hepatic injury and hepato-accumulation of (+) rugulosin in mice. J. Toxicol. Sci. 1977; 2: 261
   Google Scholar
• Uraguchi K., Saito M., Noguchi Y., Takahashi K., Enomoto M., Tatsuno T. Chronic toxicity and carcinogenicity in mice of of the purified mycotoxins, luteoskyrin and cyclochlorotine. Food Cosmet. Toxicol. 1972; 10: 193
   PubMedGoogle Scholar
• Ueno Y., Sato N., Ito T., Ueno I., Enomoto M., Tsunoda H. Chronic toxicity and hepato-carcinogenicity of (+) rugulosin, an anthraquinoid mycotoxin fromPenicillium species: preliminary surveys in mice. J. Toxicol. Sci. 1980; 5: 295
   PubMedGoogle Scholar
• Wells J. M., Cole R. J., Kirskey J. W. Emodin, a toxic metabolite of Aspergillus wentii isolated from weevil-damaged chestnuts. Appl. Microbiol. 1975; 30: 26
   PubMedGoogle Scholar
• Brown J. P., Brown R. J. Mutagenicity by 9, 10-anthraquinone derivatives and related compounds in. Salmonella typhimurium, Mutation Res. 1976; 49: 203
   Google Scholar
• Masuda T., Ueno Y. Microsomal transformation of emodin into a direct mutagen. Mutation Res. 1984; 125: 135
   PubMed Web of Science ®Google Scholar
• Ueno I., Ueno Y., Tatsuno T., Uraguchi K. Mitochondrial respiratory impairment by luteoskyrin, a hepatotoxic pigment of. Penicillium islandicum Sopp. Jpn. J. Exp. Med. 1964; 34: 135
   PubMedGoogle Scholar
• Ueno Y., Ueno I., Tatsuno T., Uraguchi K. Les effects de la lutéoskyrine, substance toxique duPenicillium islandicum Sopp, sur le gonflement des mitochondriaes. Jpn. J. Exp. Med. 1964; 34: 197
   Google Scholar
• Kawal K., Nakamaru T., Nozawa Y. The uncoupling action of skyrin and the involvement of 6.6′-hydroxy groups in the uncoupling action on mitochondrial respiration (in Japanese). Proc. Jpn. Assoc. Mycotoxicol. 1982; 15: 19
   Google Scholar
• Wirth J. G., Beesley T. E., Anand S. R. The isolation of xanthomegnin from several strains of the dermatophyte. Trichophyton rubrum, Phytochemistry 1965; 4: 505
   Google Scholar
• Robbers J. E., Hong S., Tuite J., Carlton W. W. Production of xanthomegnin and viomellein by species ofAspergillus correlated with mycotoxicosis produced in mice. Appl. Environ. Microbiol. 1978; 36: 819
   PubMed Web of Science ®Google Scholar
• Ito Y., Kawai K., Nozawa Y. Biochemical studies of pigments from the pathogenic fungus. Microsporum cookei, J. Biochem. 1973; 74: 805
   Google Scholar
• Kawai K., Cowger M. L., Nozawa Y. The redox reaction of xanthomegnin and a bypass to the electron transport system in mitochondria. Proc. Jpn. Assoc. Mycotoxicol. 1982; 15: 22
   Google Scholar
• Reddy C. S., Hayes A. W., Williams W. L., Ciegler A. Toxicity of secalonic acid D. J. Toxicol. Environ. 1979; 5: 1159
   Google Scholar
• Reddy C. S., Reddy R. V., Hayes A. W., Ciegler A. Teratogenicity of secalonic acid D in mice. J. Toxicol. Environ. Health 1981; 7: 445
   PubMed Web of Science ®Google Scholar
• Reddy C. S., Reddy R. V., Chan P. K., Hayes A. W. Mutagenicity of secalonic acid D in mice. J. Environ. Pathol. Toxicol. 1980; 4: 31
   PubMedGoogle Scholar
• Ehrlich K. C., Lee L. S., Ciegler A., Palmgren M. S. Secalonic acid D: natural contaminant of corn dust. Appl. Environ. Microbiol. 1982; 44: 1007
   PubMed Web of Science ®Google Scholar
• Kawai K., Nakamaru T., Maebayashi Y., Nozawa Y., Yamazaki M. Inhibition by secalonic acid D of oxidative phosphorylation and Ca2+-induced swelling in mitochondria isolated from rat livers. Appl. Environ. Microbiol. 1983; 46: 793
   PubMed Web of Science ®Google Scholar
• Cole R. J., Kirksey J. W., Cutler H. G., Doupnik B. J., Peckham J. C. Toxin fromFusarium moniliforme: effects on plants and animals. Science 1973; 179: 1324
   PubMed Web of Science ®Google Scholar
• Rabie C. J., Lubben A., Louw A. I., Rathbone E. B., Steyn P. S., Vleggaar R. Moniliformin, a mycotoxin from. Fusarium fusarioides, J. Agric. Food Chem. 1978; 26: 375
   PubMed Web of Science ®Google Scholar
• Kriek N. P. L., Marasas W. F. O., Steyn P. S., Van Rensburg S. J., Steyn M. Toxicity of a moniliformin-producing strain ofFusarium moniliforme var. subglutinans isolated from maize. Food Cosmet. Toxicol. 1977; 15: 579
   PubMedGoogle Scholar
• Springer J. P., Clardy J., Cole R. J., Kirksey J. W., Hill R. K., Carlson R. M., Ishidor J. L. Structure and synthesis of moniliformin, a novel cyclobutane microbial toxin. J. Am. Chem. Soc. 1974; 96: 2267
   PubMed Web of Science ®Google Scholar
• Burmeister H. R., Ciegler A., Vesonder R. F. Moniliformin, a metabolte ofFusarium moniliforme NRRL 6322: purification and toxicity. Appl. Environ. Microbiol. 1979; 37: 11
   PubMed Web of Science ®Google Scholar
• Burmeister H. R., Grove M. D., Kwolek W. F. Moniliformin and butenolide: effect on mice of high-level, long-term oral intake. Appl. Environ. Microbiol. 1980; 40: 1142
   PubMed Web of Science ®Google Scholar
• Ueno Y., Shimada N. Reconfirmation of the specific nature of reticulocyte bioassay system to trichothecene mycotoxins ofFusarium spp. Chem. Pharm. Bull. (Tokyo) 1974; 22: 2744
   Google Scholar
• Thiel P. G. A molecular mechanism for the toxic action of moniliformin, a mycotoxin produced by. Fusarium moniliforme, Biochem. Pharmacol. 1978; 27: 483
   PubMed Web of Science ®Google Scholar
• Ueno Y. Trichothecenes: overview. Mycotoxins in Human and Animal Health, J. V. Rodricks, C. W. Hesseltine, M. A. Mehlman. Pathotox, Park Forest South, Ill. 1977; 209.
   Google Scholar
• Ueno Y. Trichothecene mycotoxins: mycology, chemistry, and toxicology. Advances in Nutritional Research, Vol. 3, H. H. Drapper. Plenum Press, New York 1980; chap. 10.
   Google Scholar
• Ueno Y. Toxicological evaluation of trichothecene mycotoxins. Natural Toxins, D. Eaker, T. Wadtström. Pergamon Press, Oxford 1980; 663.
   Google Scholar
• Bamburg J. R. Chemical and biochemical studies of the trichothecene mycotoxins. Mycotoxins and Other Fungal Related Food Problems, J. V. Rodricks. American Chemical Society, Washington, D.C. 1976; 144.
   Google Scholar
• Ueno Y. Trichothecenes: Chemical, Biological and Toxicological Aspects. Elsevier/North Holland, Amsterdam 1983
   Google Scholar
• Booth C. The Genus Fusarium. Commonwealth Mycological Institute Kew, LondonEngland 1971
   Google Scholar
• Ueno Y., Sato N., Ishii K., Sakai K., Tsunoda H., Enomoto M. Biological and chemical detection of trichothecene mycotoxins ofFusarium spp. Appl. Microbiol. 1973; 25: 699
   PubMedGoogle Scholar
• Ichinoe M., Kurata H., Sugiura Y., Ueno Y. Chemotaxonomy ofGibberella zeae with special reference to production of trichothecenes and zearalenone. Appl. Environ. Microbiol. 1983; 46: 1346
   Google Scholar
• Ueno Y., Ishii K., Sato N., Shimada N., Tsunoda H., Sawano M., Enomoto M. Screening of trichothecene producing fungi and the comparative toxicity of isolated mycotoxins. Jpn. J. Pharmacol. 1973; 23: 133, (Suppl.)
   Google Scholar
• Matsuoka Y., Kubota K., Ueno Y. General pharmacological studies of fusarenon-X, a trichothecene mycotoxin fromFusarium species, Toxicol. Appl. Pharmacol. 1979; 50: 87
   PubMed Web of Science ®Google Scholar
• Matsuoka Y., Kubota K. Studies on mechanism of diarrhea induced by fusarenon-X, a trichothecene mycotoxin fromFusarium species. Toxicol. Appl. Pharmacol. 1981; 57: 293
   PubMedGoogle Scholar
• Ueno Y. Toxicological features of T-2 toxin and related trichothecenes. Fundam. Appl. Toxicol. 1984; 4, (Suppl. 124)
   Google Scholar
• Chi M. S., El-Halawani M. E., Waibel P. E., Mirocha C. J. Effects of T-2 toxin on brain catecholamines and selected blood components in growing chickens. Poultry Sci. 1981; 60: 137
   Google Scholar
• Sato N., Ueno Y., Enomoto M. Toxicological approaches to the toxic metabolites of Fusaria. VIII. Acute and subacute toxicities of T-2 toxin in cats. Jpn. J. Pharmacol. 1975; 25: 263
   PubMedGoogle Scholar
• Sato N., Ito T., Kumada H., Ueno Y., Asano K., Saito M., Ohtsubo K., Ueno I., Hatanaka Y. Toxicological approaches to the metabolites of Fusaria. VIII. Hematological changes in mice by a single and repeated administration of trichothecenes. J. Toxicol. Sci. 1978; 3: 335
   PubMedGoogle Scholar
• Rukmini C., Prasad J. S., Rao K. Effect of feeding T-2 toxin to rats and monkeys. Food Cosmet. Toxicol. 1980; 18: 267
   PubMedGoogle Scholar
• Ueno K, Kubota K. DNA-attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of. Bacillus subtilis. Cancer Res. 1976; 36: 445
   PubMed Web of Science ®Google Scholar
• Ueno K., Kubota K., Ito T., Nakamura Y. Mutagenicity of carcinogenic mycotoxins in. Salmonella ryphimurium, Cancer Res. 1978; 38: 536
   PubMedGoogle Scholar
• Schoenthal R., Joffe A. Z., Yagen B. Cardiovascular lesions and various tumors found in rats given T-2 toxin, a trichothecene metabolite of. Fusarium, Cancer Res. 1979; 39: 2179
   Google Scholar
• Saito M., Horiuchi T., Ohtsubo K., Hatanaka Y., Ueno Y. Low tumor incidence in rats given long-term feeding of fusarenon-X. Jpn. J. Exp. Med. 1980; 50: 293
   PubMedGoogle Scholar
• Watanabe T., Taguchi Y., Kitamura Y., Tsuyama K., Fugiki H., Tanooka H., Sugimura T. Biochem. Biophys. Res. Comm. 1982; 109: 478
   PubMed Web of Science ®Google Scholar
• Stanford G. K., Hood R. D., Hayes A. W. Effect of prenatal administration of T-2 toxin to mice. Res. Commun. Chem. Pathol. Pharmacol. 1975; 10: 743
   PubMedGoogle Scholar
• Khera K. S., Whalen C., Angers G., Vesonder R. F., Krlper-Goodman T. Embryotoxicity of 4-deoxynivalenol (vomitoxin) in mice. Bull. Environ. Contam. Toxicol. 1982; 29: 487
   PubMed Web of Science ®Google Scholar
• Ito Y., Ohtsubo K., Saito M. Effects of fusarenon-X. a trichothecene produced byFusarium nivale, on pregnant mice and their fetuses. Jpn. J. Exp. Med. 1980; 50: 167
   Google Scholar
• Masuko H., Ueno Y., Otokawa M., Yaginuma K. The enhansing effect of T-2 toxin on delayed hypersensitivity in mice. Jpn. J. Med. Sci. Biol. 1977; 30: 159
   PubMedGoogle Scholar
• Otokawa M. Immunological disorders. Trichothecenes, Y. Ueno. Elsevier/North Holland, Amsterdam 1983; 163
   Google Scholar
• Rosenstein Y., Lafarge-Frayssinet C., Lespinate G., Loisillier F., Lafont P., Frayssinet C. Immunosuppressive activity ofFusarium toxins effects on antibody synthesis and skin grafts of crude extracts T-2 toxin and diacetoxyscirpenol. Immunology 1979; 36: 111
   PubMed Web of Science ®Google Scholar
• Obara T., Masuda E., Takemoto T., Tatsuno T. Immunosuppressive effect of a trichothecene mycotoxin, fusarenon-X, FSN. Toxigenic Fungi: Their Toxins and Health Hazards, H. Kurata, Y. Ueno. Elsevier/North Holland, Amsterdam 1984; 301.
   Google Scholar
• Gilbert J., Shepherd M. J., Startin J. R. A survey of the occurrence of the trichothecene mycotoxin deoxynivalenol (vomitoxin) in UK grown barley and in imported maize by combined gas chromatography-mass spectrometry. J. Sci. Food Agric. 1983; 34: 86
   PubMed Web of Science ®Google Scholar
• Yoshizawa T. Red-mold diseases and natural occurrence in Japan. Trichothecenes, Y. Ueno. Elsevier/North Holland, Amsterdam 1983; 195.
   Google Scholar
• Marasas W. F. O., Van Resnburg S. J., Mirocha C. J. Incidence ofFusarium species and the mycotoxins, deoxynivalenol and zearalenone, in com produced in esophageal cancer areas in Transkei. Agric. Food Chem. 1979; 27: 1108
   PubMed Web of Science ®Google Scholar
• Ohta M., Ishii K., Ueno Y. Metabolism of trichothecene mycotoxins. I. Microsomal deacetylation of T-2 toxin in animal tissues. J. Biochem. 1977; 82: 1591
   PubMed Web of Science ®Google Scholar
• Yoshizawa T., Swanson S. P., Mirocha C. J. In vitro metabolism of T-2 toxin in rats. Appl. Environ. Microbiol. 1980; 40: 901
   PubMed Web of Science ®Google Scholar
• Yoshizawa T., Sakamoto T., Ayano Y., Mirocha C. J. 3′-Hydroxy T-2 and 3′-hydroxy HT-2 toxin: new metabolites of T-2 toxin, a trichothecene mycotoxin, in animals. Agric. Biol. Chem. 1982; 46: 2613
   Web of Science ®Google Scholar
• Yoshizawa T., Takeda H., Ohi T. Structure of a novel metabolite from deoxynivalenol, a trichothecene mycotoxin, in animals. Agric. Biol. Chem. 1983; 47: 2133
   Web of Science ®Google Scholar
• Ueno Y., Hosoya M., Morita Y., Ueno I., Tatsuno T. Inhibition of the protein synthesis in rabbit reticulocytes by nivalenol, a toxic principle isolated fromFusarium nivale-growing on rice. J. Biochem. (Tokyo) 1968; 64: 479
   PubMed Web of Science ®Google Scholar
• Wei C. M., McLaughlin C. S. Structure-function relationship in the 12, 13-epoxytrichothecenes, novel inhibitors of protein synthesis. Biochem. Biophys. Res. Comm. 1974; 75: 838
   Google Scholar
• Wei C. M., Campbell I. M., McLaughlin C. S., Maurice H. Binding of trichodermin to mammalian ribosomes and its inhibition by other 12, 13-epoxytrichothecenes. Mol. Cell Biochem. 1974; 3: 215
   PubMed Web of Science ®Google Scholar
• Fried H. M., Warner J. R. Cloning of yeast gene for trichodermin resistance and ribosomal protein L3. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 238
   PubMed Web of Science ®Google Scholar
• Tashiro F., Hirai K., Ueno Y. Inhibitory effects of carcinogenic mycotoxins on deoxyribonucleic acid-dependent ribonuclei acid polymerases and ribonuclease H. Appl. Environ. Microbiol. 1979; 38: 191
   PubMed Web of Science ®Google Scholar
• Jarvis B. B., Stahly G. P., Pavanasasivam G., Mazzola E. P. Antileukemic compounds derived from the chemical modification of macrocyclic trichothecenes. I. Derivatives of verrucarin A. J. Med. Chem. 1980; 23: 1054
   PubMed Web of Science ®Google Scholar
• Van der Merve K. J., Steyn P. S., Pourie L. Mycotoxins. II. The constitution of ocharatoxins A, B, and C, metabolites ofAspergillus ochraceus With. J. Chem. Soc. 1965; 7083
   Google Scholar
• Krogh P. Ochratoxins. Mycotoxins in Human and Animal Health, J. V. Rodricks, C. W. Hesseltine, M. A. Mehlman. Pathotox, Park Forest South, Ill. 1977; 489.
   Google Scholar
• Meister H., Selenik P. Inhibition of renal gluconeogenesis in rats by ochratoxin. Biochem. J. 1979; 180: 681
   Google Scholar
• Meister H., Cimbala M. A., Hanson R. W. Decrease of renal phosphopyruvate carboxylase RNA and poly(A)' RNA level by ochratoxin A. Arch. Biochem. Biophys. 1983; 223: 264
   Google Scholar
• Endo H. Effect of ochratoxin A on enzyme release from isolated nephron segments in rats, (in Japanese). Proc. Jpn. Assoc. Mycotoxicol. 1983; 18: 21
   Google Scholar
• Konrad I., Rösehenthaler R. Inhibition of phenylalanine tRNA synthetase fromBacillus subtilis by ochratoxin A. FEBS Lett. 1977; 83: 341
   PubMed Web of Science ®Google Scholar
• Röschenthaler R., Creppy E. E., Dreismann H., Dirheimer G. Effect of ochratoxin A on protein synthesis and immunoresponse. Proc. Jpn. Assoc. Mycotoxicol. 1983; 18: 24
   Google Scholar
• Kanisawa M., Suzuki S. Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann 1978; 69: 599
   PubMedGoogle Scholar
• Kanisawa M. Synergistic effect of citrinin on hepatorenal carcinogenesis of ochratoxin A. Toxigenic Fungi: Their Toxins and Health Hazard, H. Kurata, Y. Ueno. Elsevier/North Holland, Amsterdam 1984; 245.
   Google Scholar
• Bendele S. A., Carlton W. W., Lillehof E. B., Krogh P. Ochratoxin A carcinogenesis in the mouse, in 3rd Int. Mycolog. Congr. (abstr.), Tokyo, August 28 to September 1983; 3: 21
   Google Scholar
• Størmer F. C., Hansen C. E., Pedersen J. I., Hvistendahl G., Aasen A. J. Formation of (4R)- and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species. Appl. Environ. Toxicol. 1981; 42: 1051
   Google Scholar
• Størmer F. C., Støren O., Hansen C. E., Pedersen J. I., Aasen A. J. Formation of (4R)- and (4S)-ochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 1983; 45: 1183
   PubMed Web of Science ®Google Scholar
• Ueno Y., Yamada S., Onda T., Yoneda S. Metabolism of ochratoxin A in hepatic microsomes of rats (abstr.). 104th Annu. Meet. Jpn. Pharm. Soc., Sendai, March 28 to 30, 1984
   Google Scholar
• Creppy E. E., Størmer F. C., Röschenthaler R., Dirheimer G. Effects of two metabolites of ochratoxin A, (4R)-4-hydroxy-ochratoxin A and ochratoxin α, on the immune response in mice. Infect. Immun. 1983; 39: 1015
   PubMed Web of Science ®Google Scholar
• Borisy G. G., Marcum J. M., Olmsted J. B., Murphy D. B., Johnson K. A. Purification of tubulin and associated high molecular weight proteins from porcine brain and characterization of microtubule assembly. in vitro, Ann. N.Y. Acad. Sci. U.S.A. 1975; 253: 107
   PubMed Web of Science ®Google Scholar
• Roobol A., Gull K., Pogson C. I. Evidence that griseofulvin binds to a microtubule associated protein. FEBS Lett. 1977; 75: 149
   Google Scholar
• Binder M., Tamm Ch., Turner W. B., Minato H. Nomenclature of a class of biologically active mould metabolites: the cytochalasins, phomines, and zygosporins. J. Chem. Soc. Perkin Trans. 1973; 1: 1146
   Google Scholar
• Cytochalasins: Biochemical and Cell Biological Aspects, S. W. Tanenbaum. Elsevier/North Holland, Amsterdam 1978
   Google Scholar
• Natori S. Toxic cytochalasins. Mycotoxins in Human and Animal Health, J. V. Rodricks, C. W. Hesseltine, M. A. Mehlman. Pathotox, Park Forest South, Ill. 1977; 559.
   Google Scholar
• Glinsukon T., Shank R. C., Wogan G. N. Effects of cytochalasin E on fluid balance in the rat. Toxicol. Appl. Pharmacol. 1975; 32: 158
   Google Scholar
• Carter S. B. Effects of cytochalasins on mammalian cells. Nature (London) 1967; 213: 261
   PubMed Web of Science ®Google Scholar
• Harwig J. H., Stossel T. P. Interaction of actin, myosin, and an actin-binding protein of rabbit pulmonary macrophages. III. Effects of cytochalasin B. J. Cell Biol. 1976; 71: 295
   Google Scholar
• MacLean-Fleteher S., Pollard T. D. Mechanism of action of cytochalasin B on actin. Cell 1980; 20: 329
   Google Scholar
• Yahara I., Harada F., Sekita S., Yoshihira K., Natori S. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin. in vitro, J. Cell Biol. 1982; 92: 69
   PubMed Web of Science ®Google Scholar
• Ingermann R. L., Bissonnette J. M., Kogh P. L. D-Glucose-sensitive and -insensitive cytochalasin B binding proteins from microvillous plasma membranes of human placenta. Identification of the D-glucose transporter. Biochim. Biophys. Acta 1983; 730: 57
   Google Scholar
• Wardzala L. J., Jeanrenaud B. Identification of the D-glucose-inhibitable cytochalasin B binding site as the glucose transporter in rat diaphragm plasma and microsomal membranes. Biochem. Biophys. Acta 1983; 730: 49
   Google Scholar
• Siess W., Lapetina E. G., Cuatrecasas P. Cytochalasins inhibit arachidonic acid metabolism in thrombin-stimulated platelets. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 7709
   Google Scholar
• Marumo S. Islanditoxin, a toxic metabolite produced byPenicillium islandicum Sopp. III. Structure of islanditoxin. Bull. Agric. Chem. Jpn. 1959; 23: 428
   Google Scholar
• Uraguchi K., Tatsuno T., Sakai F., Tsukioka M., Sakai Y., Yonemitsu O., Ito H. Isolation of two toxic agents, luetoskyrin and chlorine-containing peptide, from the metabolites ofPenicillium islandicum Sopp, with some properties thereof. Jpn. J. Exp. Med. 1961; 31: 19
   PubMedGoogle Scholar
• Yoshioka H., Nakatsu K., Sato M., Tatsuno T. The molecular structure of cyclochlorotine, a toxic chlorine-containing cyclic peptide. Chem. Lett. 1972; 1319
   Google Scholar
• Ueno Y., Ito T., Hashimoto N., Ueno I. Acute toxicity of chloropeptide, a hepatotoxic metabolite of. Penicillium islandicum Sopp, J. Toxicol. Sci. 1977; 2: 349
   Google Scholar
• Ueno Y., Ito T., Matsumoto H., Sugiyama S. Acute toxicity, tissue distribution and fate of chloropeptide, a hepatotoxin ofPenicillium islandicum Sopp. Proc. Jpn. Assoc. Mycotoxicol. 1977; 5/6: 45
   Google Scholar
• Ueno Y., Ito T. Impairments of glycogen and drug-metabolisms by chloropeptide, a hepatotoxic mycotoxin ofPenicillium islandicum Sopp. J. Toxicol. Sci. 1978; 3: 11
   Google Scholar
• Ito T., Kosugi E., Niwa M., Ishikawa I., Ueno Y. Effects of chloropeptide on liver components and serum enzyme activities in mice. J. Toxicol. Sci. 1981; 6: 105
   Google Scholar
• Ueno Y., Ito T., Yoshizawa-Nakaki H., Omata Y., Ichiman K. Cytotoxicity of chloropeptide in isolated hepatocytes and its inactivation by microsomes. J. Toxicol. Sci. 1982; 7: 111
   Google Scholar
• Ueno Y., Tanaka Y., Sato K., Sakakibara K., Tachibana T., Tanaka A. Similarity in hepatotoxicity between chloropeptide and phalloidin in isolated hepatocytes. J. Toxicol. Sci. 1984; 9: 117
   Google Scholar
• Ueno Y., Sakakibara K., Nonomura T. unpublished
   Google Scholar
• Christensen C. M., Nelson G. H., Mirocha C. J. Effect on the white rat uterus of a toxic substance isolated from. Fusarium, App. Microbiol. 1965; 13: 653
   PubMedGoogle Scholar
• Urry W. H., Wehmister H. L., Hodge E. B., Hidey P. H. The structure of zearalenone. Tetrahedron Lett. 1966; 27: 3109
   Google Scholar
• National Toxicology Program Technical Report on the Carcinogenesis Bioassay of Zearalenone. Department of Health and Human Services, North Carolina 1981, NTP-91–37, DHHS Publication No. (NIH) 81–1791
   Google Scholar
• Hidy P. H., Baldwin R. S., Greasham R. L., Keith C. L., McMullen J. R. Zearalenone and some derivatives: production and biological activities. Adv. Appl. Microbiol. 1977; 22: 59
   PubMedGoogle Scholar
• Ueno Y., Shimada N., Yagasaki S., Enomoto M. Toxicological approaches to the metabolites of Fusaria. VII. Effects of zearalenone on the uteri of mice and rats. Chem. Pharm. Bull. 1974; 22: 2830
   PubMed Web of Science ®Google Scholar
• Hobson W., Bailey J., Fuller G. B. Hormone effects of zearalenone in nonhuman primates. J. Toxicol. Environ. Health 1977; 3: 43
   PubMed Web of Science ®Google Scholar
• Ueno Y., Yagasaki S. Toxicological approaches to the metabolites of Fusaria. XX. Accelerating effect of zearalenone on RNA and protein synthesis in the uterus of ovariectomized mice. Jpn. J. Exp. Med. 1970; 45: 199
   Google Scholar
• Tashiro F., Kawabata Y., Naoi M., Ueno Y. Zearalenone-estrogen receptor interaction and RNA synthesis in rat uterus. Medical Mycology, H. L. Preusser. Gustav Fisher Verlag, Stuttgart 1980; 311.
   Google Scholar
• Kawabata Y., Tashiro F., Ueno Y. Synthesis of a specific protein induced by zearalenone and its derivatives in rat uterus. J. Biochem. (Tokyo) 1982; 91: 801
   Google Scholar
• Kitagawa M., Tashiro F., Ueno Y. Interaction between zearalenone, an estrogenic mycotoxin, and the estrogen receptor of the rat brain. Proc. Jpn. Assoc. Mycotoxicol. 1982; 15: 28
   Google Scholar
• Ueno Y., Ayaki S., Sato N., Ito T. Fate and mode of action of zearalenone. Ann. Nut. Aliment. 1977; 31: 935
   PubMedGoogle Scholar
• Ueno Y., Tashiro F. Alpha-zearalenol, a major hepatic metabolite in rats of zearalenone, an estrogenic mycotoxin ofFusarium species. J. Biochem. (Tokyo) 1981; 89: 563
   PubMedGoogle Scholar
• Tashiro F., Nishimura N., Ueno Y. Metabolism of zearalenone in female rat liver. in vitro, Proc. Jpn. Assoc. Mycotoxicol. 1980; 11: 37
   Google Scholar
• Tashiro F., Shibata A., Nishimura N., Ueno Y. Zearalenone reductase from rat liver. J. Biochem. (Tokyo) 1983; 93: 1557
   Google Scholar
• Ueno Y., Tashiru F., Kobayashi T. Species difference on zearalenone-reductase activity. Food Chem. Toxicol. 1983; 21: 167
   PubMedGoogle Scholar
• Clegler A., Vesonder R. F. Tremorgenic mycotoxins. Mycotoxins and Other Fungal Related Food Problems, J. V. Rodricks. American Chemical Society, Washington, D.C. 1976; 163.
   Google Scholar
• Mantle P. G., Penny R. C. Tremorgenic mycotoxins and neurological disorders — a review. The Veterinary Animals, C. S. G. Grunsel, F. W. G. Hill. John Wright & Sons, Bristol 1981; 51.
   Google Scholar
• Yamazaki M., Suzuki S., Kuriki K. Neurotoxic studies on fumitremorgin A, a tremorgenic mycotoxin, on mice. J. Pharm, Dyn. 1979; 2: 119
   Google Scholar
• Norris P. J., Smith C. C. T., De Belleroche J., Bradford H. F., Mantel P. G., Thomas A. J., Penny R. H. C. Actions of tremorgenic fungal toxins on neurotransmitter release. J. Neurochem. 1980; 34: 33
   PubMed Web of Science ®Google Scholar
• Yamazaki M., Suzuki S., Ozaki N. Biochemical investigation on the abnormal behaviors induced by fumitremorgin A, a tremorgenic mycotoxin, to mice. J. Pharm. Dyn. 1983; 6: 748
   Google Scholar
• Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer, a study in Swaziland. Int. J. Cancer 1976; 17: 167
   PubMed Web of Science ®Google Scholar
• Bulatao-Jajame J., Almero E. M., Castro M. C. A., Jardeleza M. T. R., Salamat L. A. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Intern. J. Epidemiol. 1982; 11: 112
   Google Scholar
• Temcharoen P., Anukarahanonta T., Bhamarapravati N. Influence of dietary protein and vitamin B12 on the toxicity and carcinogenicity of aflatoxin B1 in rat liver. Cancer Res. 1978; 38: 2185
   PubMed Web of Science ®Google Scholar
• Novi A. M. Regression of aflatoxin Brinduced hepatocellular carcinomas by reduced glutathione. Science 1981; 212: 541
   PubMed Web of Science ®Google Scholar
• Wong J. J., Hsieh D. P. H. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 2241
   PubMed Web of Science ®Google Scholar
• Essigman J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr., Reihold V. N., Buchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1in vitro. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 1870
   PubMed Web of Science ®Google Scholar
• Croy R. G., Wogan G. N. Temporal patters of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981; 41: 197
   PubMed Web of Science ®Google Scholar
• Autrup H., Bradley K. A., Shamsuddin A. K. M., Wakhisi J., Wasunna A. Detection of putative adduct with fluorescence characteristics identical to 2, 3-dihydro-2-(7′-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis 1983; 4: 1193
   PubMed Web of Science ®Google Scholar
• Hertzog P. J., Smith J. R. L., Garner R. C. Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B1 DNA, the presistent DNA adduct. in vitro, Carcinogenesis 1982; 3: 825
   PubMed Web of Science ®Google Scholar
• Chestsanga C. J., Frenette G. P. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formaminopyrimidine-DNA glycosylase. Carcinogenesis 1983; 4: 997
   Google Scholar
• Swanson D. H., Miller J. A., Miller E. C. The reactivity and carcinogenicity of aflatoxin B1-2, 3-dichloride, a model for the putative 2, 3-oxide metabolite of aflatoxin B1. Cancer Res. 1975; 35: 3811
   Google Scholar
• Greopman J. D., Busby W. F., Wogan G. N. Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver. in vivo, Cancer Res. 1980; 40: 4343
   Google Scholar
• Yoshizawa H., Uchimaru R., Ueno Y. Metabolism of aflatoxin B1 in the nuclei isolated from rat liver. J. Biochem. (Tokyo) 1981; 89: 443
   Google Scholar
• Gurtoo H. L. Genetic expression of aflatoxin B1 metabolism; effects of 3-methylcholantrene and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxan on the metabolism of aflatoxin B1 and B2 by various inbred strains of mice. Mol. Pharmacol. 1980; 18: 296
   Google Scholar
• Raina V., Williams C. J., Gortoo H. L. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and β-naphtoflavone on hepatic microsomal metabolism and mutagenic activities of aflatoxins. Biochem. Pharmacol. 1983; 32: 3755
   PubMed Web of Science ®Google Scholar
• Yoshizawa H., Uchimaru R., Kamataki T., Kato R., Ueno Y. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. Cancer Res. 1982; 42: 1120
   PubMed Web of Science ®Google Scholar
• Ueno Y., Ishii K., Omata Y., Kamataki T., Kato R. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b2 in the activation of aflatoxin B1. Carcinogenesis 1983; 4: 1071
   PubMedGoogle Scholar
• Ueno Y., Tashiro F., Nakaki H. Mechanism of metabolic activation of aflatoxin B1. Gann 1985; 30: 111
   Google Scholar
• Rascati R. J., McNeely M. Induction of retrovirus gene expression by aflatoxin B1 and 2-acetylam-inofluorene. Mutation Res. 1983; 122: 235
   Google Scholar